United States · 
Who invested in R1 Therapeutics?
R1 Therapeutics's investors include F-Prime Capital, Abingworth, DaVita, SymBiosis and curie.bio, and 1 more on record. F-Prime Capital led its latest round.
United States · Series A startup
Who invested in R1 Therapeutics
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 8 months ago
Follow R1 Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$78Mraised across 1 round since 2026, from 1 source
- Latest round
- Series A, $78MMar 2026
- Led by
- F-Prime Capital and Abingworthand 1 more
- Investors
- 6 (3 led)
The rounds
- Mar 2026Series A$78M
Reported by TechStartups
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about R1 Therapeutics
How much has R1 Therapeutics raised?
R1 Therapeutics has raised $78M across 1 round since 2026.
When did R1 Therapeutics last raise?
R1 Therapeutics's most recent round was a Series A of $78M in Mar 2026, led by F-Prime Capital.
What was R1 Therapeutics's biggest round?
Its most recent round, $78M in Mar 2026, is also its largest on record.
Who backed R1 Therapeutics first?
R1 Therapeutics's first round on record, in Mar 2026, was backed by F-Prime Capital, Abingworth and DaVita and 3 others.
What stage is R1 Therapeutics at?
R1 Therapeutics's latest named round is a Series A, in Mar 2026.
Where is R1 Therapeutics based?
R1 Therapeutics is based in the United States.
Who led R1 Therapeutics's rounds?
F-Prime Capital led the Series A in 2026.
Companies like R1 Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.